glabellar frown lines
Showing 1 - 25 of 52
Glabellar Frown Lines Trial (PROTOXIN)
Not yet recruiting
- Glabellar Frown Lines
- PROTOXIN
- (no location specified)
Nov 8, 2023
Adjuvant Zinc May Increase the Efficacy of Botulinum Toxin, Zinc Supplementation for Botulinum Toxin Treatment of the Forehead,
Not yet recruiting
- Adjuvant Zinc May Increase the Efficacy of Botulinum Toxin
- +4 more
- zinc citrate 50 mg
- Placebo Microcrystalline Cellulose
- (no location specified)
May 30, 2023
Glabellar Frown Lines Trial (onabotulinumtoxinA at a depth of 2mm, onabotulinumtoxinA at a depth of 4mm)
Not yet recruiting
- Glabellar Frown Lines
- onabotulinumtoxinA at a depth of 2mm
- onabotulinumtoxinA at a depth of 4mm
- (no location specified)
Mar 9, 2023
Glabellar Frown Lines Trial in Seoul (ATGC-110, Xeomin®)
Active, not recruiting
- Glabellar Frown Lines
- ATGC-110
- Xeomin®
-
Seoul, Korea, Republic ofNowon Eulji Medical Center
Feb 2, 2023
Glabellar Frown Lines Trial in Miami (AI-09, Vehicle)
Recruiting
- Glabellar Frown Lines
- AI-09
- Vehicle
-
Miami, FloridaBaumann Cosmetic & Research Institute
Oct 11, 2022
Glabellar Frown Lines Trial in Canada, United States (botulinum toxin, Placebo)
Completed
- Glabellar Frown Lines
- botulinum toxin
- Placebo
-
Manhattan Beach, California
- +13 more
Sep 23, 2022
Glabellar Frown Lines Trial in Germany, United Kingdom (Alluzience, powder BoNT-A (BOTOX/Vistabel))
Active, not recruiting
- Glabellar Frown Lines
- Alluzience
- powder BoNT-A (BOTOX/Vistabel)
-
Bochum, Germany
- +7 more
Sep 9, 2022
Glabellar Frown Lines Trial (PROTOXIN, Botox®)
Not yet recruiting
- Glabellar Frown Lines
- PROTOXIN
- Botox®
- (no location specified)
Aug 16, 2022
Glabellar Frown Lines Trial in Canada, United States (Botulinum Toxins, Type A, Placebos)
Completed
- Glabellar Frown Lines
- Botulinum Toxins, Type A
- Placebos
-
Encinitas, California
- +13 more
Jun 29, 2022
Glabellar Frown Lines Trial in United States (Botulinum Toxins, Type A, Placebos)
Completed
- Glabellar Frown Lines
- Botulinum Toxins, Type A
- Placebos
-
Birmingham, Alabama
- +14 more
Jun 29, 2022
Glabellar Frown Lines Trial in Canada, United States (Botulinum Toxins, Type A)
Completed
- Glabellar Frown Lines
- Botulinum Toxins, Type A
-
Birmingham, Alabama
- +60 more
Jun 16, 2022
Glabellar Frown Lines Trial in Boca Raton (PrabotulinumtoxinA-Xvfs, OnabotulinumtoxinA)
Active, not recruiting
- Glabellar Frown Lines
-
Boca Raton, FloridaAesthetic Eyelid Plastic Surgery
Jul 6, 2022
Glabellar Frown Lines Trial in Seoul (MBA-P01)
Recruiting
- Glabellar Frown Lines
-
Seoul, Dongjak-gu, Korea, Republic ofChung-Ang Univ. Hospital
Apr 4, 2022
Glabellar Frown Lines Trial in Seoul (ATGC-100 100U, Botox 100U)
Completed
- Glabellar Frown Lines
- ATGC-100 100U
- Botox 100U
-
Seoul, Korea, Republic ofNowon Eulji University Hospital
Mar 22, 2022
Glabellar Frown Lines Trial in Encino, Los Angeles (IncobotulinumtoxinA)
Not yet recruiting
- Glabellar Frown Lines
-
Encino, California
- +1 more
Mar 30, 2022
Glabellar Frown Lines Trial in Encino (prabotulinumtoxinA)
Recruiting
- Glabellar Frown Lines
-
Encino, CaliforniaClinical Testing of Beverly Hills
Mar 30, 2022
Glabellar Frown Lines Trial in Seoul (MBA-P01 (Botulinum toxin A), Placebo)
Recruiting
- Glabellar Frown Lines
- MBA-P01 (Botulinum toxin A)
- Placebo
-
Seoul, Dongjak-gu, Korea, Republic ofChung-And Univ. Hospital
Jan 26, 2022
Glabellar Frown Lines, Canthal Lines Trial in New York (QM1114-DP)
Not yet recruiting
- Glabellar Frown Lines
- Canthal Lines
- QM1114-DP
-
New York, New YorkLuxurergy
Nov 23, 2021
Glabellar Frown Lines Trial in United States (QM1114-DP, Placebo)
Not yet recruiting
- Glabellar Frown Lines
- QM1114-DP
- Placebo
-
Homewood, Alabama
- +4 more
Nov 23, 2021
Glabellar Frown Lines Trial in Seoul (PROTOXIN, Botox®)
Completed
- Glabellar Frown Lines
- PROTOXIN
- Botox®
-
Seoul, Korea, Republic of
- +1 more
Aug 8, 2021
Glabellar Frown Lines Trial in Nashville (Botulinum Toxin A, Placebo)
Completed
- Glabellar Frown Lines
- Botulinum Toxin A
- Placebo
-
Nashville, TennesseeTennessee Clinical Research Center
May 18, 2021